Digoxin in advanced heart failure patients: A question of rhythm

Revista Portuguesa de Cardiologia

Volumn 32, Issue 4, 2013, Pages 303-310

  Jorge, Elisabete ^a   Baptista, Rui ^a   Martins, Hélia ^a   Saraiva, Fátima ^a   Costa, Susana ^a   Vieira, Henrique ^a   Coelho, Lourenço ^a   Monteiro, Pedro ^a   Franco, Fátima ^a   Provid̂encia, Luís A ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Advanced heart failure; Atrial fibrillation; Digoxin; Prognosis

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOSIMENDAN; NORADRENALIN; SPIRONOLACTONE; WARFARIN;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SINUS RHYTHM; TREATMENT OUTCOME;

EID: 84879269079     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2012.11.007     Document Type: Article

References (20)

1. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:e1-82.
2. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001;22:1527-60. (Pubitemid 32801300)
3. Dobbs SM, Kenyon WI, Dobbs RJ. Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients. Br Med J. 1977;1:749-52. (Pubitemid 8052988)
4. Guyatt GH, Sullivan MJ, Fallen EL, et al. A controlled trial of digoxin in congestive heart failure. Am J Cardiol. 1988;61:371-5.
5. Lee DC, Johnson RA, Bingham JB, et al. Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med. 1982;306:699-705. (Pubitemid 12183620)
6. Uretsky BF, Young JB, Shahidi FE, et al. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol. 1993;22:955-62. (Pubitemid 23285742)
7. Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med. 1993;329:1-7. (Pubitemid 23182871)
8. The Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with Captopril and digoxin in patients with mild to moderate heart failure. JAMA. 1988;259:539-44.
9. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525-33.
10. Lader E, Egan D, Hunsberger S, et al. The effect of digoxin on the quality of life in patients with heart failure. J Card Fail. 2003;9:4-12. (Pubitemid 36356696)
11. Khand AU, Rankin AC, Martin W, et al. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol. 2003;42:1944.
12. Butler J, Anand I, Kuskowski M, et al. Higher mortality and adverse cardiovascular outcomes risk with digoxin use in patients with heart failure: a Val-HeFT substudy. Circulation. 2005;Suppl. II:641.
13. Georgiopoulou V, Kalogeropoulos A, Giamouzis G, et al. Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy. Circ Heart Fail. 2009;2:90-7.
14. Swedberg K, Komajda M, Bohm M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised controlled study. Lancet. 2010;376:875-85.
15. Poole-Wilson PA, Swedberg K, Cleland JGF, et al. Comparison of Carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362:7-13. (Pubitemid 36835815)
16. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709-17. (Pubitemid 29407370)
17. Pitt B, Bakris G, Ruilope LM, et al. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Circulation. 2008;118:1643-50.
18. Ahmed A, Pitt B, Rahimtoola S, et al. Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial. Int J Cardiol. 2008:138-46. (Pubitemid 350258580)
19. Ahmed A, Waagstein F, Pitt B, et al. Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group Trial. Am J Cardiol. 2009;103:82-7.
20. Cleland J, Cullington D. Digoxin, Quo Vadis? Circ Heart Fail. 2009;2:81-5.